Abstract
In comparison to other European countries, during the first months of the COVID-19 pandemic, Poland reported a relatively low number of confirmed cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. To estimate the scale of the pandemic in Poland, a serosurvey of antibodies against SARS-CoV-2 was performed after the first wave of COVID-19 in Europe (March–May 2020). Within this study, we collected samples from 28 July to 24 September 2020 and, based on the ELISA results, we found that 1.67% (25/1500, 95% CI 1.13–2.45) of the Poznan (Poland) metropolitan area’s population had antibodies against SARS-CoV-2 after the first wave of COVID-19. However, the presence of anti-SARS-CoV-2 IgG antibodies was confirmed with immunoblotting in 56% (14/25) samples, which finally resulted in a decrease in seroprevalence, i.e., 0.93% (14/1500, 95% CI 0.56–1.56). The positive anti-SARS-CoV-2 IgG results were associated with age, occupation involving constant contact with people, travelling abroad, non-compliance with epidemiological recommendations and direct contact with the novel coronavirus. Our findings confirm the low SARS-CoV-2 incidence in Poland and imply that the population had little herd immunity heading into the second and third wave of the pandemic, and therefore, that herd immunity contributed little to preventing the high numbers of SARS-CoV-2 infections and COVID-19-related deaths in Poland during these subsequent waves.
Highlights
The emergence and rapid spread across the globe of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected almost every aspect of life
The presence of anti-SARS-CoV-2 IgG antibodies was confirmed with immunoblotting in 56% (14/25) samples, which resulted in a decrease in seroprevalence, i.e., 0.93% (14/1500, 95% CI 0.56–1.56)
Due to the non-specific symptoms or asymptomatic course of novel coronavirus infection, the diagnosis is based on the detection of viral genetic material by the molecular techniques, i.e., reverse transcription and polymerase chain reaction (RT-PCR) or loop-mediated isothermal amplification (LAMP) [4,5]
Summary
The emergence and rapid spread across the globe of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected almost every aspect of life. The SARS-CoV-2 virus can cause coronavirus disease 2019 (COVID-19), which is manifested by non-specific symptoms, such as fever, cough, fatigue and rapid loss of taste and smell. The SARS-CoV-2 infection can be asymptomatic [3]. Due to the non-specific symptoms or asymptomatic course of novel coronavirus infection, the diagnosis is based on the detection of viral genetic material by the molecular techniques, i.e., reverse transcription and polymerase chain reaction (RT-PCR) or loop-mediated isothermal amplification (LAMP) [4,5]. The RT-PCR is a gold standard in the diagnosis of SARS-CoV-2 infection due to its high sensitivity and specificity, internal controls of the reaction as well as the possibility of running many samples at once [6,7]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.